CA Stock MarketDetailed Quotes

Novo Nordisk AS (NVON)

Watchlist
  • 4.540
  • +0.200+4.61%
15min DelayMarket Closed May 1 15:59 ET
20.13BMarket Cap0.91P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Novo Nordisk AS (NVON) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
6.43%309.06B
-7.63%79.14B
5.14%74.98B
12.93%76.86B
19.49%78.09B
25.03%290.4B
30.09%85.68B
21.42%71.31B
25.34%68.06B
22.45%65.35B
Operating revenue
7.18%729.42B
-7.63%79.14B
5.14%74.98B
12.93%76.86B
19.49%78.09B
11.82%680.56B
-80.63%85.68B
21.42%71.31B
25.34%68.06B
22.45%65.35B
Cost of revenue
32.04%58.79B
16.31%15.15B
58.33%17.9B
25.03%12.85B
29.99%12.89B
24.48%44.52B
30.06%13.02B
16.42%11.31B
30.78%10.27B
21.19%9.92B
Gross profit
1.79%250.28B
-11.92%64B
-4.88%57.07B
10.77%64.01B
17.61%65.2B
25.13%245.88B
30.10%72.66B
22.41%60B
24.42%57.79B
22.68%55.43B
Operating expense
4.32%122.62B
-10.19%32.26B
27.54%33.39B
-4.05%30.56B
11.95%26.41B
25.15%117.54B
23.52%35.92B
18.44%26.18B
41.21%31.85B
16.89%23.59B
Selling and administrative expenses
4.31%70.28B
-14.02%17.44B
7.76%17.88B
17.14%18.85B
11.79%16.11B
9.38%67.38B
8.89%20.28B
17.88%16.59B
4.39%16.09B
6.90%14.41B
-Selling and marketing expense
3.56%64.31B
-15.04%15.89B
5.17%16B
17.40%17.53B
12.34%14.89B
9.44%62.1B
8.92%18.7B
18.65%15.21B
4.13%14.93B
6.80%13.26B
-General and administrative expense
13.13%5.97B
-1.96%1.55B
36.32%1.88B
13.74%1.32B
5.45%1.22B
8.67%5.28B
8.52%1.58B
10.03%1.38B
7.93%1.16B
8.03%1.16B
Research and development costs
8.27%52.04B
6.13%14.65B
62.24%15.39B
-27.69%11.69B
19.78%10.31B
48.14%48.06B
31.95%13.8B
16.73%9.49B
126.83%16.17B
27.91%8.61B
Other operating expenses
-85.73%300M
-90.54%174M
15.84%117M
105.68%23M
-102.46%-14M
1,867.23%2.1B
61,400.00%1.84B
203.06%101M
-2,800.00%-405M
1,821.21%568M
Operating profit
-0.53%127.66B
-13.61%31.74B
-29.98%23.68B
28.98%33.45B
21.81%38.79B
25.12%128.34B
37.25%36.74B
25.67%33.82B
8.56%25.93B
27.35%31.85B
Net non-operating interest income (expenses)
-3,393.41%-3.18B
307.54%2.45B
226.51%1.84B
159.14%356M
-2,541.67%-1.76B
-127.58%-91M
-28.82%-1.18B
-51.13%562M
-264.48%-602M
126.67%72M
Non-operating interest income
-30.96%1.27B
-37.41%2.45B
32.68%1.84B
453.54%5.31B
59.60%3.43B
71.94%1.84B
238.76%3.91B
-58.32%1.38B
48.38%960M
151.88%2.15B
Non-operating interest expense
156.52%4.21B
-186.51%-4.41B
----
217.41%4.96B
149.90%5.18B
202.58%1.64B
342.41%5.09B
-62.13%821M
455.87%1.56B
84.85%2.07B
Total other finance cost
-16.61%241M
----
----
----
----
46.70%289M
----
----
----
----
Other net income (expenses)
673.42%6.06B
-159.72%-1.06B
Gain on sale of security
684.42%6.08B
----
----
----
----
-161.57%-1.04B
----
----
----
----
Income before tax
2.63%130.54B
-3.86%34.19B
-25.79%25.52B
33.45%33.81B
16.03%37.03B
21.51%127.19B
28.74%35.56B
22.52%34.38B
4.44%25.33B
29.03%31.92B
Income tax
7.26%28.11B
-0.45%7.29B
-22.19%5.51B
38.24%7.3B
22.85%8B
24.83%26.2B
29.52%7.33B
26.82%7.08B
9.45%5.28B
32.26%6.51B
Earnings from equity interest net of tax
Net income
1.43%102.43B
-4.74%26.89B
-26.72%20.01B
32.18%26.5B
14.28%29.03B
20.68%100.99B
28.53%28.23B
21.46%27.3B
3.20%20.05B
28.23%25.41B
Net income continuous operations
1.43%102.43B
-4.74%26.89B
-26.72%20.01B
32.18%26.5B
14.28%29.03B
20.68%100.99B
28.53%28.23B
21.46%27.3B
3.20%20.05B
28.23%25.41B
Noncontrolling interests
Net income attributable to the company
1.43%102.43B
-4.74%26.89B
-26.72%20.01B
32.18%26.5B
14.28%29.03B
20.68%100.99B
28.53%28.23B
21.46%27.3B
3.20%20.05B
28.23%25.41B
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
1.43%102.43B
-4.74%26.89B
-26.72%20.01B
32.18%26.5B
14.28%29.03B
20.68%100.99B
28.53%28.23B
21.46%27.3B
3.20%20.05B
28.23%25.41B
Diluted earnings per share
1.72%23.06
-4.42%6.06
-26.59%4.5
32.44%5.96
14.74%6.54
21.42%22.67
28.86%6.34
22.11%6.13
3.93%4.5
29.55%5.7
Basic earnings per share
1.77%23.03
-4.73%6.04
-26.47%4.5
32.74%5.96
14.96%6.53
21.54%22.63
29.12%6.34
22.40%6.12
3.94%4.49
29.38%5.68
Dividend per share
0.7347
0
0.2836
0
0.4511
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 6.43%309.06B-7.63%79.14B5.14%74.98B12.93%76.86B19.49%78.09B25.03%290.4B30.09%85.68B21.42%71.31B25.34%68.06B22.45%65.35B
Operating revenue 7.18%729.42B-7.63%79.14B5.14%74.98B12.93%76.86B19.49%78.09B11.82%680.56B-80.63%85.68B21.42%71.31B25.34%68.06B22.45%65.35B
Cost of revenue 32.04%58.79B16.31%15.15B58.33%17.9B25.03%12.85B29.99%12.89B24.48%44.52B30.06%13.02B16.42%11.31B30.78%10.27B21.19%9.92B
Gross profit 1.79%250.28B-11.92%64B-4.88%57.07B10.77%64.01B17.61%65.2B25.13%245.88B30.10%72.66B22.41%60B24.42%57.79B22.68%55.43B
Operating expense 4.32%122.62B-10.19%32.26B27.54%33.39B-4.05%30.56B11.95%26.41B25.15%117.54B23.52%35.92B18.44%26.18B41.21%31.85B16.89%23.59B
Selling and administrative expenses 4.31%70.28B-14.02%17.44B7.76%17.88B17.14%18.85B11.79%16.11B9.38%67.38B8.89%20.28B17.88%16.59B4.39%16.09B6.90%14.41B
-Selling and marketing expense 3.56%64.31B-15.04%15.89B5.17%16B17.40%17.53B12.34%14.89B9.44%62.1B8.92%18.7B18.65%15.21B4.13%14.93B6.80%13.26B
-General and administrative expense 13.13%5.97B-1.96%1.55B36.32%1.88B13.74%1.32B5.45%1.22B8.67%5.28B8.52%1.58B10.03%1.38B7.93%1.16B8.03%1.16B
Research and development costs 8.27%52.04B6.13%14.65B62.24%15.39B-27.69%11.69B19.78%10.31B48.14%48.06B31.95%13.8B16.73%9.49B126.83%16.17B27.91%8.61B
Other operating expenses -85.73%300M-90.54%174M15.84%117M105.68%23M-102.46%-14M1,867.23%2.1B61,400.00%1.84B203.06%101M-2,800.00%-405M1,821.21%568M
Operating profit -0.53%127.66B-13.61%31.74B-29.98%23.68B28.98%33.45B21.81%38.79B25.12%128.34B37.25%36.74B25.67%33.82B8.56%25.93B27.35%31.85B
Net non-operating interest income (expenses) -3,393.41%-3.18B307.54%2.45B226.51%1.84B159.14%356M-2,541.67%-1.76B-127.58%-91M-28.82%-1.18B-51.13%562M-264.48%-602M126.67%72M
Non-operating interest income -30.96%1.27B-37.41%2.45B32.68%1.84B453.54%5.31B59.60%3.43B71.94%1.84B238.76%3.91B-58.32%1.38B48.38%960M151.88%2.15B
Non-operating interest expense 156.52%4.21B-186.51%-4.41B----217.41%4.96B149.90%5.18B202.58%1.64B342.41%5.09B-62.13%821M455.87%1.56B84.85%2.07B
Total other finance cost -16.61%241M----------------46.70%289M----------------
Other net income (expenses) 673.42%6.06B-159.72%-1.06B
Gain on sale of security 684.42%6.08B-----------------161.57%-1.04B----------------
Income before tax 2.63%130.54B-3.86%34.19B-25.79%25.52B33.45%33.81B16.03%37.03B21.51%127.19B28.74%35.56B22.52%34.38B4.44%25.33B29.03%31.92B
Income tax 7.26%28.11B-0.45%7.29B-22.19%5.51B38.24%7.3B22.85%8B24.83%26.2B29.52%7.33B26.82%7.08B9.45%5.28B32.26%6.51B
Earnings from equity interest net of tax
Net income 1.43%102.43B-4.74%26.89B-26.72%20.01B32.18%26.5B14.28%29.03B20.68%100.99B28.53%28.23B21.46%27.3B3.20%20.05B28.23%25.41B
Net income continuous operations 1.43%102.43B-4.74%26.89B-26.72%20.01B32.18%26.5B14.28%29.03B20.68%100.99B28.53%28.23B21.46%27.3B3.20%20.05B28.23%25.41B
Noncontrolling interests
Net income attributable to the company 1.43%102.43B-4.74%26.89B-26.72%20.01B32.18%26.5B14.28%29.03B20.68%100.99B28.53%28.23B21.46%27.3B3.20%20.05B28.23%25.41B
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 1.43%102.43B-4.74%26.89B-26.72%20.01B32.18%26.5B14.28%29.03B20.68%100.99B28.53%28.23B21.46%27.3B3.20%20.05B28.23%25.41B
Diluted earnings per share 1.72%23.06-4.42%6.06-26.59%4.532.44%5.9614.74%6.5421.42%22.6728.86%6.3422.11%6.133.93%4.529.55%5.7
Basic earnings per share 1.77%23.03-4.73%6.04-26.47%4.532.74%5.9614.96%6.5321.54%22.6329.12%6.3422.40%6.123.94%4.4929.38%5.68
Dividend per share 0.734700.283600.4511
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -